LAS VEGAS, Dec. 06, 2017 (GLOBE NEWSWIRE) — The Infertility Treatment Market was worth USD 0.78 billion in the year of 2014 and is expected to reach approximately USD 1.93 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 10.63% during the forecast period. Infertility means not having the capacity to become pregnant, inside specific parameters. Infertility is a common issue of around 10 percent of women from the age 15 to 44. Infertility can be because of the woman, the man or because of obscure issues. Infertility in men can be because of low or absent sperm count, varicocele, sperm damage or certain sicknesses. Risk factors for men’s infertility incorporate drug use and alcohol, health problems, toxins, smoking, radiation, age, medicines, and chemotherapy. Several factors like increasing consciousness of the public about infertility and the accessible treatment alternatives, constant decline in rates of fertility, the increasing rate of fertility clinics globally, and mechanical progressions in infertility treatment are the key boosters for the growth of the market of infertility treatment. Nonetheless, the high procedural expenses and unfavorable government controls for some infertility treatment alternatives are foreseen to inhibit market development to a certain extent.
Get Sample copy of this Report @: https://www.crystalmarketresearch.com/report-sample/HC12396
The infertility treatment market by procedure is segmented into Assisted Reproductive Technology (ART), Fertility Surgeries, Artificial Insemination and Others. On the basis of product the market is segmented into Accessories, Media & Consumables and Instruments. In terms of patient type the market is segmented into Male Treatment and Female Treatment. On the basis of end user the market is segmented into Hospitals and Clinic, Research Institutes, Cryobanks and Fertility Centers.
In terms of regions, the market is segmented into North America, Asia Pacific, Europe and rest of the world. In 2016 North America possessed the largest share of the market, which was followed by Europe and Asia-Pacific. The Asia-Pacific area is anticipated to grow at a tremendous rate during the estimate time frame. This growth can be attributed to elements such as increasing medical tourism, increasing population, reductions in treatment prices, growing healthcare expenditure.
The leading players in the market are IVFtech ApS, Irvine Scientific, Thermo Fisher Scientific Inc, Genea Limited, Esco Micro Pte. Ltd, Vitrolife AB, The Baker Company Inc and Cook Group Incorporated. The leading players are profiled in detail in view of qualities, for example, business strategies, company portfolio, recent developments, financial overview, and share of the overall industry.
Get customization of this Report @ https://www.crystalmarketresearch.com/customization/HC12396
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
Toll Free: + 1-888-213-4282